Malignant lymphoma outlined

Malignant lymphoma is the lymph nodes and extranodal sites of immune cells lymphoid tissue tumor cells derived from the lymphocytes or malignant transformation. Although China's malignant lymphoma in relatively rare, but in recent years new cases increased year by year, every year at least more than 25,000 cases, while in Europe, the Americas and Australia, and other Western countries the incidence rates can be as high as 11/10 million to 18/10 million. slightly more than the sum of various types of leukemia. At least annually in the United States found new cases 30,000 above. The mortality rate of malignant lymphoma for 1.5/10 million, the median of all cancer deaths in the first 11 to 13, with leukemia similar. Moreover, malignant lymphoma in China has some characteristics: ① higher morbidity and mortality rates in central coastal areas; ② age of onset of the peak is about 40, not Europe and the United States bimodal curve, and with Japan was a single peak similar; ③ proportion of Hodgkin's disease than in European and American countries, but there are increasing trend; ④ in non-Hodgkin's lymphoma in the very low percentage of follicular, accounts for the vast majority of diffuse; ⑤ nearly a decade information indicates that the Chinese T-cell lymphoma accounted for 34 percent, and Japan similar, much larger than Europe and the United States.